Plasma taurine and cysteine levels following an oral methionine load: Relationship with coronary heart disease

European Journal of Clinical Nutrition

Volumn 58, Issue 1, 2004, Pages 105-109

  Obeid, O A ^a,c   Johnston, K ^b   Emery, Peter W ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Coronary heart disease; Cysteine; Methionine; Taurine; Vitamin B6

Indexed keywords

CYSTEINE; METHIONINE; PYRIDOXAL 5 PHOSPHATE; PYRIDOXIC ACID; TAURINE;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID SYNTHESIS; ARTICLE; ASIAN; BLOOD SAMPLING; CASE CONTROL STUDY; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; EUROPE; HUMAN; INDIAN; ISCHEMIC HEART DISEASE; LOADING TEST; MALE; RACE; RANDOMIZATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VITAMIN BLOOD LEVEL;

ADULT; CASE-CONTROL STUDIES; CORONARY DISEASE; CYSTEINE; EUROPE; FASTING; HUMANS; INDIA; MALE; METHIONINE; MIDDLE AGED; PYRIDOXAL PHOSPHATE; PYRIDOXIC ACID; TAURINE;

EID: 0742272162     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1601755     Document Type: Article

References (24)

1. Bates CJ, Pentieva KD, Matthews N & Macdonald A (1999): A simple, sensitive and reproducible assay for pyridoxal-5-phosphate and 4-pyridoxic acid in human plasma. Clin. Chim. Acta 280, 101-111.
2. Bender DA (1985): Amino Acid Metabolism, 2nd Edition. Chichester: John Wiley and Sons.
3. Brattstrom L, Lindgren A, Israelsson B, Andersson A & Hultberg B (1994): Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J. Intern. Med. 236, 633-641.
4. Chambers JC, Obeid OA, Refsum H, Ueland P, Hackett D, Hooper J, Turner RM, Thompson SG & Kooner JS (2000): Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 355, 523-527.
5. El-Khairy L, Ueland PM, Refsum H, Graham IM & Vollset SE (2001): Plasma total cysteine as a risk factor for vascular disease: the European concerted action project. Circulation 103, 2544-2549.
6. Fennessy F, Smith G, Kelly C & Bouchier-Hayes D (1998): Taurine restores endothelial-dependent but not independent dysfunction in young cigarette smokers. Br. J. Surg. 85, 1582.
7. Finkelstein JD (1990): Methionine metabolism in mammals. J. Nutr. Biochem. 1, 228-237.
8. Fiskerstrand T, Refsum H, Kvalheim G & Ueland PM (1993): Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin. Chem. 39, 263-271.
9. Folsom AR, Javier NF, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH, Hess DL & Davis CE (1998): Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms and B vitamins: the atherosclerosis risk in comunities (ARIC) study. Circulation 98, 204-210.
10. Fujita T, Ando K, Noda H, Ito Y & Sato Y (1987): Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension. Circulation 75, 525-532.
11. Hankey JH & Eikelboom JW (1999): Homocysteine and vascular disease. Lancet 354, 407-413.
12. Mann GE, Smith S, Norman PSR & Emery PW (1988): Fasting, refeeding and diabetes modulate free amino acid concentrations in the rat exocrine pancreas: role of transstimulation in amino acid efflux. Pancreas 3, 67-76.
13. Mansoor MA, Asbjorn AM, Schneede J & Ueland P (1992): Dynamic relation between reduced, oxidised, and protein-bound homocysteine and other thiol components in plasma during methionine loading in healthy men. Clin. Chem. 38, 1316-1321.
14. Marks DB, Marks AD & Smith CM (1996): Basic Medical Biochemistry: A Clinical Approach. London: Williams and Wilkins.
15. McCarty MF (1999): The reported clinical utility of taurine in ischemic disorders may reflect a down-regulation of neutrophil activation and adhesion. Med. Hypotheses 53, 290-299.
16. McCully KS (1996): Homocysteine and vascular disease. Nat. Med. 2, 386-389.
17. Miller JW, Nadeau MR, Smith D & Selhub J (1993): Vitamin B-6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats. Am. J. Clin. Nutr. 59, 1033-1039.
18. Mizushima S, Nara Y, Sawamura M & Yamori Y (1996): Effects of oral taurine supplementation on lipids and sympathetic nerve tone. In Taurine, Vol 2, eds R. Huxtable, J Azuma, K Kuriyama, M Nakagawa & A Baba, Adv. Exp. Med. Biol. 403, 615-622. New York: Plenum Press.
19. 6 depletion in adult man on the excretion of cystathionine and other methionine metabolites. J. Nutr. 100, 110-116.
20. Robinson K, Mayer EL, Miller DP, Green R, van Lente F, Gupta A, Kottke-Marchant K, Savon SR, Selhub J, Nissen S, Kutner M, Topol EJ & Jacobsen DW (1995): Hyperhomocysteinemia and low pyridoxal phosphate: common and independent reversible risk factors for coronary artery disease. Circulation 92, 2825-2830.
21. Suliman ME, Divino Filho JC, Barany P, Anderstam B, Lindholm B & Bergstrom J (2001) Effects of methionine loading on plasma and erythrocyte sulphur amino acids and sulph-hydrils before and after co-factor supplementation in haemodialysis patients. Nephrol. Dial. Transplant. 16, 102-110
22. Ubbink JB, van der Merwe A, Delport R, Allen RH, Stabler S, Riezler R & Hayward Vermaak WJ (1996): The effect of subnormal vitamin B-6 status on homocysteine metabolism. J. Clin. Invest. 98, 177-184.
23. Yamori Y, Liu L, Ikeda K, Miura A, Mizushima S, Miki T & Nara Y (2001): Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Hypertens Res. 24, 453-457.
24. Yamori Y, Nara Y, Ikeda K & Mizushima S (1996): Is taurine a preventive nutritional factor of cardiovascular diseases or just a biological marker of nutrition? In Taurine, Vol 2, eds R Huxtable, J Azuma, K Kuriyama, M Nakagawa & A Baba, Adv. Exp. Med. Biol. 403, 623-629. New York: Plenum Press.